HEADER TRANSFERASE/INHIBITOR 16-JUN-22 7Y4T TITLE CRYSTAL STRUCTURE OF CMET KINASE DOMAIN BOUND BY COMPOUND 9I COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE INHIBITOR, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.Z.QU,Y.H.CHEN REVDAT 3 29-NOV-23 7Y4T 1 REMARK REVDAT 2 07-DEC-22 7Y4T 1 JRNL REVDAT 1 23-NOV-22 7Y4T 0 JRNL AUTH C.WANG,J.LI,L.QU,X.TANG,X.SONG,F.YANG,X.CHEN,Q.LIN,W.LIN, JRNL AUTH 2 Y.ZHOU,Z.TU,Y.CHEN,Z.ZHANG,X.LU JRNL TITL DISCOVERY OF D6808, A HIGHLY SELECTIVE AND POTENT JRNL TITL 2 MACROCYCLIC C-MET INHIBITOR FOR GASTRIC CANCER HARBORING MET JRNL TITL 3 GENE ALTERATION TREATMENT. JRNL REF J.MED.CHEM. V. 65 15140 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36355693 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00981 REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 23530 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1196 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5000 - 4.4800 1.00 2649 176 0.1946 0.2260 REMARK 3 2 4.4800 - 3.5600 1.00 2565 109 0.1920 0.2465 REMARK 3 3 3.5600 - 3.1100 1.00 2472 137 0.2224 0.2472 REMARK 3 4 3.1100 - 2.8300 1.00 2459 139 0.2475 0.2890 REMARK 3 5 2.8300 - 2.6200 1.00 2467 122 0.2391 0.2813 REMARK 3 6 2.6200 - 2.4700 1.00 2444 128 0.2496 0.3165 REMARK 3 7 2.4700 - 2.3500 1.00 2427 120 0.2556 0.3043 REMARK 3 8 2.3500 - 2.2400 1.00 2436 126 0.2488 0.2493 REMARK 3 9 2.2400 - 2.1600 1.00 2415 139 0.2666 0.2998 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -16.9970 5.3755 -21.3408 REMARK 3 T TENSOR REMARK 3 T11: 0.2532 T22: 0.5247 REMARK 3 T33: 0.3748 T12: -0.0100 REMARK 3 T13: -0.0070 T23: -0.0363 REMARK 3 L TENSOR REMARK 3 L11: 0.1516 L22: 2.1926 REMARK 3 L33: 1.7634 L12: -0.2864 REMARK 3 L13: -0.3052 L23: 0.7128 REMARK 3 S TENSOR REMARK 3 S11: -0.0353 S12: -0.1597 S13: 0.0460 REMARK 3 S21: 0.0471 S22: 0.1408 S23: -0.0380 REMARK 3 S31: 0.2492 S32: -0.0730 S33: 0.0006 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Y4T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1300030253. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97915 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23530 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 29.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 22.40 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.1600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 6SD9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES (PH 7.8), 15-30% (V/V) PEG REMARK 280 8000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 95.24750 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 32.95850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 32.95850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 47.62375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 32.95850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 32.95850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 142.87125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 32.95850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 32.95850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 47.62375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 32.95850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 32.95850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 142.87125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 95.24750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1059 REMARK 465 PRO A 1060 REMARK 465 GLU A 1061 REMARK 465 LEU A 1062 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1346 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CG CD OE1 NE2 REMARK 470 GLN A1067 CG CD OE1 NE2 REMARK 470 HIS A1068 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A1086 CG CD NE CZ NH1 NH2 REMARK 470 ASN A1100 CG OD1 ND2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 ARG A1114 CG CD NE CZ NH1 NH2 REMARK 470 ILE A1118 CG1 CG2 CD1 REMARK 470 GLU A1127 CG CD OE1 OE2 REMARK 470 ARG A1148 CG CD NE CZ NH1 NH2 REMARK 470 SER A1152 OG REMARK 470 LYS A1215 CG CD CE NZ REMARK 470 LYS A1232 CG CD CE NZ REMARK 470 LYS A1323 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A1101 CB - CA - C ANGL. DEV. = -23.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A1153 92.19 5.14 REMARK 500 ARG A1203 -2.23 69.41 REMARK 500 ASP A1204 49.57 -148.39 REMARK 500 ALA A1221 -158.37 -124.58 REMARK 500 LYS A1240 -71.97 -101.02 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Y4T A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQRES 1 A 309 GLY ASP SER ASP ILE SER SER PRO LEU LEU GLN ASN THR SEQRES 2 A 309 VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 3 A 309 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 4 A 309 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 5 A 309 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 6 A 309 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 7 A 309 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 8 A 309 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 9 A 309 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 10 A 309 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 11 A 309 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 12 A 309 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 13 A 309 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 15 A 309 VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS SEQRES 16 A 309 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 17 A 309 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 18 A 309 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 19 A 309 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 20 A 309 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 21 A 309 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 22 A 309 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 23 A 309 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 24 A 309 ILE SER ALA ILE PHE SER THR PHE ILE GLY HET I90 A1401 34 HETNAM I90 2-[2-[3-(1-METHYLPYRAZOL-4-YL)QUINOLIN-6-YL]ETHYL]-6- HETNAM 2 I90 (3-NITROPHENYL)PYRIDAZIN-3-ONE FORMUL 2 I90 C25 H20 N6 O3 FORMUL 3 HOH *97(H2 O) HELIX 1 AA1 GLN A 1064 HIS A 1068 5 5 HELIX 2 AA2 GLY A 1072 SER A 1074 5 3 HELIX 3 AA3 ASP A 1117 ILE A 1129 1 13 HELIX 4 AA4 ILE A 1130 PHE A 1134 5 5 HELIX 5 AA5 ASP A 1164 ASN A 1171 1 8 HELIX 6 AA6 THR A 1177 LYS A 1198 1 22 HELIX 7 AA7 ALA A 1206 ARG A 1208 5 3 HELIX 8 AA8 PHE A 1223 ARG A 1227 5 5 HELIX 9 AA9 ASP A 1231 GLU A 1233 5 3 HELIX 10 AB1 LYS A 1248 MET A 1250 5 3 HELIX 11 AB2 ALA A 1251 GLN A 1258 1 8 HELIX 12 AB3 THR A 1261 THR A 1278 1 18 HELIX 13 AB4 ASP A 1291 GLN A 1298 1 8 HELIX 14 AB5 PRO A 1309 TRP A 1320 1 12 HELIX 15 AB6 LYS A 1323 ARG A 1327 5 5 HELIX 16 AB7 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 6 VAL A1070 ILE A1071 0 SHEET 2 AA1 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 AA1 6 LEU A1154 PRO A1158 -1 O VAL A1156 N GLY A1144 SHEET 4 AA1 6 LYS A1104 SER A1111 -1 N ALA A1108 O LEU A1157 SHEET 5 AA1 6 GLY A1090 LEU A1098 -1 N TYR A1093 O VAL A1109 SHEET 6 AA1 6 LEU A1076 GLY A1087 -1 N ILE A1084 O VAL A1092 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 2 TYR A1235 VAL A1237 0 SHEET 2 AA3 2 LYS A1244 PRO A1246 -1 O LEU A1245 N SER A1236 CRYST1 65.917 65.917 190.495 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015171 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015171 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005249 0.00000